Bumper Offer - Urjas oil Just @ Rs. 1
Emigo is a prescription medicine that is available as a Injection, Solution, Tablet. Nausea and Vomiting are some of its major therapeutic uses.
The optimal dosage of Emigo is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
While these are the most often observed Emigo side effects, there are can be others also. These have been listed below. Usually, these side effects of Emigo go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
In addition, Emigo's effect is Safe during pregnancy and Mild for lactating mothers. It is important to know if Emigo has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Emigo related warnings section.
Emigo is not recommended if you suffer from certain medical conditions as it can have adverse effects. Heart Disease, Calcium Deficiency, Potassium Deficiency are examples of such conditions. Other conditions have been mentioned below in the Emigo contraindications section.
Additionally, Emigo may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Emigo, it is important to know that it is not safe while driving, and is not habit-forming.
Emigo is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Infant (1 month to 2 years) |
|
| 2 - 12 years (Child) |
|
| 13 - 18 years (Adolescent) |
|
Based on research, the following side effects have been observed when Emigo is used -
Moderate
Mild
Is the use of Emigo safe for pregnant women?
There are no side effects of Emigo in pregnant women.
Is the use of Emigo safe during breastfeeding?
Emigo has been seen to have minimal side effects on breastfeeding women.
What is the effect of Emigo on the Kidneys?
Emigo is not harmful for kidneys.
What is the effect of Emigo on the Liver?
There may be an adverse effect on the liver after taking Emigo. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Emigo on the Heart?
Emigo can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Emigo should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Emigo unless your doctor advises you to do so -
Is this Emigo habit forming or addictive?
Forming a habit of Emigo has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Emigo you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, Emigo is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Emigo cannot treat any kind of mental disorder.
Interaction between Food and Emigo
Taking Emigo with food does not harm your health.
Interaction between Alcohol and Emigo
Taking alcohol with Emigo can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 947-948
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 668
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran (ondansetron hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran® (ondansetron hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 947-948
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 668
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran (ondansetron hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran® (ondansetron hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 947-948
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 668
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran (ondansetron hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran® (ondansetron hydrochloride)